{
  "generated": "2025-11-05T06:51:34.197117+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/psychological/ashwagandha-mh-ash-cort/mental_health/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "MH-ASH-CORT_01",
      "year": 2009,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "stress_resilience",
      "population": "Adults with stress resilience concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/mh-ash-cort-01",
      "url": "https://doi.org/10.1234/mh-ash-cort-01",
      "citation": "MH-ASH-CORT_01 (2009); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with stress resilience concerns; Outcome: stress_resilience; DOI: 10.1234/mh-ash-cort-01; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "MH-ASH-CORT_02",
      "year": 2010,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "stress_resilience",
      "population": "Adults with stress resilience concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/mh-ash-cort-02",
      "url": "https://doi.org/10.1234/mh-ash-cort-02",
      "citation": "MH-ASH-CORT_02 (2010); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with stress resilience concerns; Outcome: stress_resilience; DOI: 10.1234/mh-ash-cort-02; Adverse Events: Transient headache."
    },
    {
      "study_id": "MH-ASH-CORT_03",
      "year": 2011,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "stress_resilience",
      "population": "Adults with stress resilience concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/mh-ash-cort-03",
      "url": "https://doi.org/10.1234/mh-ash-cort-03",
      "citation": "MH-ASH-CORT_03 (2011); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with stress resilience concerns; Outcome: stress_resilience; DOI: 10.1234/mh-ash-cort-03; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/mh-ash-cort-01",
      "study_ids": [
        "MH-ASH-CORT_01"
      ],
      "primary_study_id": "MH-ASH-CORT_01",
      "url": "https://doi.org/10.1234/mh-ash-cort-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/mh-ash-cort-02",
      "study_ids": [
        "MH-ASH-CORT_02"
      ],
      "primary_study_id": "MH-ASH-CORT_02",
      "url": "https://doi.org/10.1234/mh-ash-cort-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/mh-ash-cort-03",
      "study_ids": [
        "MH-ASH-CORT_03"
      ],
      "primary_study_id": "MH-ASH-CORT_03",
      "url": "https://doi.org/10.1234/mh-ash-cort-03"
    }
  ],
  "manifest_hash": "sha256:90ff4255a7da890b3aa4d1b86734002231547d1a730eb2ae64b628429287c22d"
}
